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AsthmaDisparities During the COVID-19 Pandemic:
A Survey of Patients and Physicians
Alan P. Baptist, MD, MPH, FAAAAIa, Desmond Lowe, BSb, Nadeen Sarsour, BSb, Hannah Jaffee, MSc,
Sanaz Eftekhari, BScc, Laurie M. Carpenter, MSWa, and Priya Bansal, MDd Ann Arbor, Mich; Arlington, Va; and St Charles,
Ill
What is already known about this topic? There is a disproportionate impact of coronavirus disease 2019 (COVID-19) on
minority individuals. For minority individuals with asthma, the extent of, and reasons for, these disparities is not fully
known.
What does this article add to our knowledge? Minority individuals with asthma are more likely to be affected (directly or
indirectly) by COVID-19. Differences in attitudes toward COVID-19 between minority and white individuals disappear once
socioeconomic and asthma characteristics are controlled.
How does this study impact current management guidelines? Health disparities exist for patients with asthma during
the COVID-19 pandemic, and addressing underlying socioeconomic factors as well as institutional racism can help to
decrease these disparities.
BACKGROUND: The coronavirus disease 2019 (COVID-19)
pandemic has demonstrated signi!cantly worse outcomes for
minority (black and Hispanic) individuals. Understanding the
reasons for COVID-19erelated disparities among patients with
asthma has important public health implications.
OBJECTIVE: To determine factors contributing to health
disparities in those with asthma during the COVID-19
pandemic.
METHODS: An anonymous survey was sent through social
media to adult patients with asthma, and a separate survey was
sent to physicians who provide asthma care. The patient survey
addressed demographic information including socioeconomic
status, asthma control, and attitudes/health behaviors during
COVID-19.
RESULTS: A total of 1171 patients (10.1% minority individuals)
and 225 physicians completed the survey. Minority patients were
more likely to have been affected by COVID-19 (eg, became
unemployed, lived in a community with high COVID-19 cases).
They had worse asthma control (increased emergency visits for
asthma, lower Asthma Control Test score), were more likely to
live in urban areas, and had a lower household income. Initial
differences in attitudes and health behaviors disappeared after
controlling for baseline demographic features. Institutional
racism was demonstrated by !ndings that minority individuals
were less likely to have a primary care physician, had more
trouble affording asthma medications due to COVID-19, and
were more likely to have lost health insurance because of
COVID-19, and that 25% of physicians found it more
challenging to care for black individuals with asthma during
COVID-19.
CONCLUSIONS: Differences in socioeconomic status and the
effects of institutional racism, but not health behaviors, sources
of information, or attitudes, are playing a role in disparities seen
for patients with asthma during COVID-19. ! 2020 American
Academy of Allergy, Asthma & Immunology (J Allergy Clin
Immunol Pract 2020;-:---)
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INTRODUCTION
The coronavirus disease 2019 (COVID-19) pandemic has
been a catastrophic event, with more than 2.5 million cases and
more than 125,000 deaths in the United States by the end of
June 2020.1 Initial reports suggest that a number of individuals
would be considered “high risk” for increased severe illness and
mortality from COVID-19, including those with hypertension,
diabetes, cardiovascular disease, and respiratory diseases.2 Asthma
is a respiratory disease, and initially patients with asthma of any
severity were considered high risk according to the United States
Centers for Disease Control and Prevention (CDC). More
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ACT- Asthma Control Test
CDC- Centers for Disease Control and Prevention
LABA- Long-acting beta-agonist
OR- Odds ratio
recently, as new evidence has emerged regarding the associations
between asthma and COVID-19 outcomes,3,4 the CDC has
updated its guidelines to include only those with moderate to
severe asthma as those who might be at increased risk for severe
illness from COVID-19.5
Although underlying comorbidities such as asthma are
potential risk factors, one of the most striking !ndings during the
COVID-19 pandemic has been the incredible health disparities
demonstrated in outcomes. For example, black individuals
account for nearly 70% of deaths from COVID-19 in Chicago,
despite representing only 30% of the population.6 In addition,
the COVID-19 death rate among Hispanic individuals is
signi!cantly higher than that among non-Hispanic individuals in
New York (74.3 vs 45.2 per 100,000, respectively).7 Such
disparities in COVID-19 outcomes have renewed attention on
other conditions with signi!cant health disparities, such as
asthma. Although the prevalence of asthma among black in-
dividuals is somewhat higher than that among white individuals
(10.7 vs 8.0%, respectively), black individuals experience
signi!cantly worse outcomes. Asthma mortality rates are nearly 3
times higher in non-Hispanic blacks than in non-Hispanic
whites (22.7 vs 8.1 per million).1 In addition, asthma hospital-
ization rates are 4 to 5 times higher for black individuals than for
white individuals.8,9
The reasons for these extreme disparities in both COVID-19
and asthma outcomes may be multifactorial. Although genetic
factors may play a role,10 these differences have been attributed
more strongly to socioeconomic factors including environmental
in"uences.11,12 In addition, differences in cultural beliefs, atti-
tudes, and health-seeking behaviors may contribute to disparities
in asthma.13 Finally, institutional racism (which refers to the
systemic practices or individual attitudes that result in the
blocking of people of color from the distribution of resources)
has been recognized as another factor that promotes health
disparities.14 A better understanding of the contribution and
interaction of these elements is critical to develop programs to
eliminate health disparities.
The purpose of this study was to determine the underlying
factors (including demographic and asthma characteristics,
patient behaviors, and physician attitudes or perceived barriers)
that may be contributing to health disparities in those with
asthma during the COVID-19 pandemic.
METHODS
This project was designed as an anonymous survey sent to
individuals with asthma. In addition, a short survey was developed
and sent to physicians who provide care for patients with asthma.
The study was approved by the University of Michigan Institutional
Review Board, and given the anonymous design signed consent was
not required.
Survey development for patients with asthma
The questionnaire was developed by the survey development
team. The survey development team comprised 10 individuals from
multiple states including rural, suburban, and urban areas. It was
multidisciplinary and included individuals with asthma, primary care
physicians, asthma specialists, and medical students. Minority in-
dividuals were part of the team, as were public health professionals
with speci!c interests in health disparities, and leadership from the
Asthma and Allergy Foundation of America. Face validity evaluation
of the questionnaire was performed initially with a small group of
patient and physician volunteers, who evaluated the survey for
language clarity, ease of completion, timing, and health literacy, and
whose feedback was incorporated before survey distribution. The
survey was designed to be completed in 20 minutes.
Individuals with asthma were eligible to participate if they were
older than 18 years and currently had asthma. The survey obtained
basic demographic information including age, sex, and race/
ethnicity. Medical comorbidities other than asthma (hay fever, heart
disease, high blood pressure, stroke, cancer, depression, heart burn,
and diabetes) were assessed. Asthma-speci!c information included
National Institutes of Healtherecommended measures of asthma
assessment (the Asthma Control Test [ACT], emergency
department/urgent care visits in the previous year, hospitalizations in
the previous year, requirement for intensive care unit admission
ever, and asthma medications). The survey also ascertained items
such as medication compliance and asthma severity (mild,
moderate, or severe). All information on the survey was obtained
through self-report, and subjects were not compensated for their
participation.
In discussions during survey development with individuals with
asthma, we identi!ed areas of concern during the COVID-19
pandemic. Items included in the survey related to stress, suscepti-
bility to COVID-19 in patients with asthma, social distancing
practices, overlapping symptoms, attitudes toward the government
response to the pandemic, and sources of COVID-related infor-
mation. In addition, individuals discussed concerns related to
COVID-19 care in the setting of institutional racism. We therefore
included questions related to household income, living environment
(rural, urban, suburban/peri-urban), employment challenges from
COVID-19, health insurance changes, medication accessibility, and
!nancial worries.
Survey distribution
Distribution of the survey was performed through social media
(primarily Facebook and Twitter) as well as through patient email
Listserves and the Asthma and Allergy Foundation of America
website. Through social media, a post with a link to the survey was
placed on multiple Facebook asthma group pages, inviting
individuals with asthma to participate. To ensure an adequate
representation of minority subjects, an invitation to participate was
also placed on Facebook group pages for African Americans. The
survey remained open for a 3-week period in the period April to
May 2020.
Physician survey development and distribution
A separate survey was developed for physicians who provide care
to patients with asthma. This survey was also developed by the
survey development team. The survey underwent face validity testing
with a group of primary care provider and asthma specialist
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TABLE II. Challenges faced by patients with asthma during COVID-19
Challenges White Minority P value
Unemployed due to COVID-19 16.1 (135) 29.1 (34) .001
Dif"culty getting asthma medicines during COVID-19 12.8 (108) 20.5 (24) .023
Live in community with high number of cases 44.1 (371) 54.2 (64) .038
Diagnosed with COVID-19 1.5 (13) 3.4 (4) .153
Lost health insurance because of COVID-19 2.3 (19) 4.2 (5) .197
Have had symptoms of COVID-19 34.8 (293) 38.5 (45) .432
Essential employee 25.3 (213) 23.9 (28) .750
Data presented as % (n).
Bold indicates statistical signi"cance (P < .05).
TABLE I. Patients’ demographic characteristics
Characteristic White (n [ 845) Minority (n [ 118) P value
Age (y), mean ! SD 26.0 – 12.4 20.2 – 12.6 <.001
Sex: female 88.0 (743) 70.3 (83) <.001
Household income ($) <.001
$25,000 7.3 (60) 20.5 (23)
25,000-49,999 15.9 (130) 25.9 (29)
50,000-$74,999 16.2 (132) 12.5 (14)
75,000-99,999 17.7 (145) 14.3 (16)
100,000" 42.8 (350) 26.8 (30)
Currently live <.001
Urban 19.7 (166) 38.1 (45)
Peri-urban/suburban 56.7 (477) 50.8 (60)
Rural 23.6 (199) 11.0 (13)
Comorbidities
Heart disease 3.9 (32) 3.6 (4) .869
Hypertension 21.1 (174) 24.5 (27) .415
Depression 38.4 (313) 35.7 (40) .582
GERD 41.3 (339) 33.3 (38) .102
Diabetes 6.6 (53) 5.5 (6) .645
Seasonal allergies 88.1 (734) 85.3 (99) .393
Have a PCP 94.4 (798) 89.0 (105) .022
Have asthma specialist 37.0 (313) 30.5 (36) .167
Age at asthma diagnosis (y), mean ! SD 20.8 ! 15.1 16.8 ! 13.8 .006
Asthma ED in past year 25.3 (213) 35.0 (41) .025
ICU or intubation ever for asthma 6.0 (51) 16.1 (19) <.001
Asthma severity .122
Mild 44.2 (373) 39.0 (46)
Moderate 45.0 (380) 44.9 (53)
Severe 8.1 (68) 14.4 (17)
Not sure 2.7 (23) 1.7 (2)
Current asthma medications
Albuterol 93.6 (791) 93.2 (110) .872
Montelukast 34.8 (294) 27.1 (32) .099
ICS 24.7 (209) 23.7 (28) .812
ICS w/LABA 41.9 (354) 36.4 (43) .26
Oral steroids 4.7 (40) 9.3 (11) .037
Biologics 3.6 (30) 5.1 (6) .41
ACT score, mean ! SD 18.5 – 4.8 17.4 – 4.8 .018
ACT uncontrolled (score # 19) 47.9 (404) 59.0 (69) .024
ED, Emergency department; GERD, gastroesophageal re!ux disease; ICS, inhaled corticosteroid; LABA, long-acting beta-agonist; PCP, primary care physician.
Data presented as % (n) unless otherwise noted.
Bold indicates statistical signi"cance (P < .05).
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physicians, who provided suggestions on content and timing, which
were incorporated before survey distribution. Speci!c questions
related to the care of minority patients, and instances of perceived
institutional racism, were included. These questions related to
obstacles when managing black patients’ asthma, outcomes of black
patients with asthma during COVID-19, additional challenges
during COVID-19 when dealing with black patients, and
compliance of black patients with asthma medications during
COVID-19. The physician survey was distributed through social
media (primarily through Facebook physician group pages) and also
through physician email Listserves. Physicians were informed that 20
survey respondents would randomly be chosen to receive a $100
Amazon gift card. Please see this article’s Online Repository at www.
jaci-inpractice.org for both patient and physician surveys.
Statistical analysis
Individuals with asthma were considered to be minority status if
they selected a race category of black or if they answered they were
Hispanic. Individuals with asthma were considered to be white if
they selected a race category of white and no other races. Compar-
isons between groups were performed using c2 analysis. To control
for differences in baseline demographic and asthma-speci!c
information, regression models were constructed (logistic regres-
sion for dichotomous independent variables, multinomial regression
models for ordinal variables) and baseline characteristics that were




A total of 1355 individuals submitted a survey. After removing
responses from those who were younger than 18 years or who
responded that they did not currently have asthma, 1171 surveys
were available for analysis. Of these surveys, 845 (72.2%) were
from white individuals whereas 118 (10.1%) were from minority
(black or Hispanic) individuals. The remaining 208 individuals
did not specify a racial category or were not one of the race
categories above and were excluded from further analysis.
Demographics and asthma control
Of all respondents, 98% resided in the United States. As
shown in Table I, white respondents were more likely to be
female and older. Items related to institutional racism found that
minority respondents had a lower household income, were less
likely to have a primary care physician, and were more likely to
live in an urban environment. In regard to asthma, minority
individuals reported worse asthma control, because they required
more frequent emergency department visits for asthma in the
previous year, were more likely to have required intubation for
asthma, and were more likely to require daily oral corticosteroids.
In addition, minority individuals had a lower ACT score, and
were more likely to have an “uncontrolled” asthma score (#19)
on the ACT. Minority individuals were also more likely to only
have a rescue medication and not be on a controller medication.
Although self-reported asthma severity appeared worse in
minority individuals, and speci!c controller use also appeared
lower in minority populations, neither of these reached statistical
signi!cance. When examining comorbidities (heart disease,
hypertension, depression, gastroesophageal re"ux disease,
diabetes, or seasonal allergies), no differences were found.
COVID-19especific differences
Related to COVID-19, minority respondents were more likely
to have become unemployed because of COVID-19, had more
dif!culty obtaining asthma medications during the pandemic,
and were more likely to respond that they lived in a community
with a high number of COVID-19 cases (Table II). Although
minority respondents were more likely to have been diagnosed
with COVID-19, to have had symptoms of COVID-19, and to
have lost health insurance because of COVID-19, none of these
reached statistical signi!cance.
The survey also examined where patients with asthma were
getting their sources of information related to COVID-19. As
shown in Figure 1, there were no differences between the 2
groups, with more than 80% of respondents selecting social
media as one of their primary source of information. We next
examined whether the respondents felt differently about the
government response to the pandemic. Just over 50% of both
groups felt that the CDC had a good understanding about the
risks associated with COVID-19 to patients with asthma, but
signi!cantly more minority individuals felt that both the federal
and state government responses were inadequate (Table III).
When examining behaviors and attitudes that could contribute
to the spread of COVID-19, we found that there were no dif-
ferences in social distancing practices and that approximately
80% of both groups noted they were taking the pandemic more
seriously than others (Table III).
Minority individuals were more likely to feel that individuals
with asthma were at a higher risk of contracting COVID-19, that
people with asthma should not work during the COVID-19
pandemic, and that stress is a major trigger for asthma
(Figure 2). Approximately 20% of both groups felt that asthma
medications could make a COVID-19 infection worse, and more
minority individuals felt that asthma medications would make an
individual more likely to get a COVID-19 infection (13.7 vs
8.6%; P $ .077). Both groups were worried that they would not
be able to tell the difference between asthma symptoms and
COVID-19 symptoms. Similarly, both groups had high levels of
anxiety about getting COVID-19, and both groups reported
more anxiety than those without asthma during this time.
FIGURE 1. Asthma patient’s source for information about COVID-
19. Each patient could select up to 3 sources. PCP, Primary care
physician.




We next examined whether differences in attitudes between
minority and white respondents persisted after controlling for
demographic and asthma-speci!c factors. After controlling for
signi!cant differences presented in Table I, there was no differ-
ence in attitudes related to asthma medications increasing the
risk of COVID-19, the necessity of individuals with asthma to
stay home from work, attitudes about federal or state response to
COVID-19, or the ability to know the difference between
COVID-19 and asthma symptoms (see Table E1 in this article’s
Online Repository at www.jaci-inpractice.org). However, after
controlling for confounding variables from Table I, minority
individuals remained more likely to feel that those with asthma
were more likely to get COVID-19 (odds ratio, 1.61; P $ .037).
Physician responses
A total of 225 physicians who care for patients with asthma
completed a brief survey. The demographic characteristics of
these physicians are listed in Table E2 in this article’s Online
Repository at www.jaci-inpractice.org. Brie"y, the physicians
were primarily primary care physicians (62.1%) and asthma
specialists (31.9%) who had been in practice for an average of
10.7 years. Only 1.4% of respondents were black and 4.0% were
Hispanic.
When inquiring about the administration of care for patients,
24% of physician respondents felt it was more dif!cult to care for
black patients during COVID-19 and 28% of physician re-
spondents noted they encounter more obstacles when managing
asthma for a black patient. Figure 3 shows the percent of
respondents who answered “Somewhat agree” or “Strongly agree”
for each of 5 statements related to caring for black patients with
asthma during COVID-19.
DISCUSSION
Since March 2020, the COVID-19 pandemic has dispro-
portionately impacted minority populations in the United States.
For decades, asthma outcomes have also been signi!cantly worse
among these same populations. This study was designed to
determine the underlying factors that may be contributing to
health disparities in those with asthma during the COVID-19
pandemic. We found that socioeconomic factors and institu-
tional racism, but not health-seeking behaviors or cultural
factors, appear to play a signi!cant role.
This study demonstrated that the COVID-19 pandemic has
been particularly dif!cult for minority individuals with asthma.
For example, minority individuals reported they were more likely
to have had a COVID-19 infection (though this did not reach
statistical signi!cance), more likely to have lost their jobs because
of COVID-19, more likely to have dif!culties obtaining asthma
medications during COVID-19, and more likely to live in a
community with a high number of cases (which may have been
in"uenced by higher rates of urban residence). Such disparities
may partially explain why minority individuals were signi!cantly
more likely to feel that both the state and federal governments
were not doing enough during the COVID-19 pandemic. The
study also reaf!rmed socioeconomic disparities among minority
individuals (eg, lower income levels), and worse control of
asthma on multiple domains (eg, emergency visits and ACT
score). We next wanted to determine whether differences in
health-seeking behaviors and attitudes were responsible for the
TABLE III. Attitudes and behaviors during COVID-19
Attitudes and behaviors White Minority P value
Since COVID-19, taking medicines .687
More regularly than normal 41.3 (241) 45.8 (33)
Less regularly than normal 3.4 (20) 4.2 (3)
About the same as normally 55.3 (323) 50.0 (36)
As of today, taking pandemic .251
Much more seriously than others 47.7 (403) 58.5 (69)
A little more seriously than others 29.0 (245) 24.6 (29)
With about same seriousness as others 19.8 (167) 15.3 (18)
Less seriously than others 3.6 (30) 1.7 (2)
CDC has good understanding about risks 55.1 (461) 61.0 (72) .229
Federal government response is .016
Too much 4.5 (38) 1.7 (2)
Just right 26.8 (226) 16.9 (20)
Too little 68.6 (578) 81.4 (96)
State government response is .001
Too much 10.1 (85) 5.1 (6)
Just right 66.8 (563) 55.9 (66)
Too little 23.1 (195) 39.0 (46)
As of today, I am .259
Interacting with others as usual 0.7 (6) 0.8 (1)
Social distancing 5.0 (42) 6.8 (8)
Only essential trips, interacting as usual 1.8 (15) 4.2 (5)
Only essential trips and social distancing 72.4 (612) 64.4 (76)
Completely isolating 20.1 (170) 23.7 (28)
Data presented as % (n).
Bold indicates statistical signi"cance (P < .05).
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worse outcomes between minority and white populations with
asthma. Although multiple differences were initially found, after
adjusting for the baseline socioeconomic and asthma control
differences, these virtually all disappeared.
The !nding that minority individuals with asthma have
similar health-seeking behaviors and practices as white in-
dividuals has important public health implications. Both groups
felt that the CDC has a good understanding about the risks for
patients with asthma with COVID-19 (55%-60% agree), both
groups are using the same social distancing practices, and both
groups report an increased compliance with asthma medications
due to COVID-19. Just as importantly, the sources of
information related to COVID-19 are the same in both groups.
Therefore, a “minority-speci!c” campaign to distribute infor-
mation related to COVID-19 for patients with asthma may not
be effective.
This study also demonstrates that institutional racism may be
a factor in the care of patients with asthma during the COVID-
19 pandemic. Institutional racism is de!ned as “the collective
failure of an organization to provide an appropriate and profes-
sional service to people because of their color, culture, or ethnic
origin.”15 It does not require the actions or intent of
individuals,16 but rather because of an establishment of patterns,
procedures, practices, and policies within organizations,
institutional racism penalizes and exploits people because of their
race.17 As it pertains to medical care, examples in this study
include !ndings that minority individuals were signi!cantly
more likely to have lost health insurance during COVID-19, to
live in urban environments (where hospitals are often under
signi!cant !nancial constraints and are underresourced),18 to
have dif!culty affording asthma medications during COVID-19,
and were less likely to have a primary care physician. Nearly 30%
of physicians noted they encountered more obstacles when
providing asthma care for black patients than for white patients,
and approximately 25% of physicians felt that during COVID-
19, it was more challenging to care for black patients.
Although not fully explored in this study, both institutional
racism and individual physician implicit bias can contribute to
health disparities in asthma. For example, physician responses
regarding dif!culties caring for minority patients may be related
to factors such as perceived dif!culties in affording medications,
baseline health status, or attending of!ce visits (examples of an
institutional-wide problem). However, even when controlling for
socioeconomic factors, previous studies have found unequal
outcomes for minority individuals, thought to be due to larger
FIGURE 2. Percent of patients with asthma who agree with each statement regarding COVID-19. ER, Emergency room; hosp, hospital;
meds, medicines. *P # .05.
FIGURE 3. Percent of physicians who agree with each of the
following statements regarding the care of patients with asthma
during COVID-19. Meds, Medicines.
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social inequalities within societies, of which socioeconomic status
is only one part.19 Another possibility is that implicit bias may be
contributing to institutional racism,20 and implicit bias has been
found to be prevalent among health care workers.21 Unlike overt
racism, implicit bias refers to attitudes or stereotypes that affect
understanding, actions, and decisions in an unconscious manner.
One way to help overcome implicit bias is through workshops
and education, which can improve clinical outcomes for
minorities.22 In July 2020, in response to the disparities seen in
COVID-19 outcomes, the state of Michigan issued a
directive requiring all medical professionals to take implicit bias
training—the !rst state to do so.23
There are limitations to this study. Because this was sent
through social media and email, both patients and physicians
who do not use this form of communication would be excluded.
The age and socioeconomic status of the participants may not be
representative of all patients with asthma or physicians, because
those in the lowest socioeconomic strata who may be most
vulnerable to COVID-19 are least likely to use social media.24
Additional factors that may in"uence asthma outcomes (eg,
obesity and environmental tobacco exposure) were not assessed.
Answers to all survey questions were self-reported and not
veri!ed through medical chart review. Given the method of
distribution, it was not possible to calculate a response rate nor to
evaluate whether those who responded were different than those
who did not. The surveys were validated for face but not content
validity. Testing of implicit bias in physician respondents was not
done, because validated tools (such as the Implicit Association
Test25) often take a signi!cant amount of time to administer. A
complete analysis of the factors contributing to institutional and
systemic racism was not carried out. Follow-up questions or
focus groups were not performed to further elucidate responses
by patients or providers. Finally, because the study is cross-
sectional rather than a prospective trial, cause and effect cannot
be proven but rather associations between worse outcomes and
factors.
CONCLUSIONS
Differences in socioeconomic factors and the effects of
institutional racism, but not health-seeking behaviors, are playing
a role in disparities seen for patients with asthma during
COVID-19. There are challenges in correcting such differences,
but it is critical to do so to eliminate health disparities.
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TABLE E1. Regression analysis for attitudes/opinions among minority patients with asthma
Attitudes/opinions Odds ratio 95% CI P value
Patients with asthma more likely to get COVID-19 1.61 1.03 2.5 .037
Asthma medications increase the risk of COVID-19 1.46 0.753 2.84 .261
Stress is a major trigger for asthma 1.34 0.853 2.1 .205
Individuals with asthma should not go to work 1.21 0.743 1.96 .447
Federal government response is inadequate 4.83 0.631 36.9 .13
State government response is inadequate 2.29 0.838 6.28 .247
ED, Emergency department; ICU, intensive care unit; PCP, primary care physician.
Controlled for age, age of diagnosis, COVID in community, PCP, urban living, sex, household income, unemployed from COVID, ACT score, asthma ED visits, need for ICU
visit, asthma medication adherence, and dif"culties getting medicines.
Bold indicates statistical signi"cance (P < .05).
TABLE E2. Physician demographics
Demographics n [ 225 %
Specialty
Internal Medicine 49 21.8
Pediatrics 47 20.9
















Age (y), mean ! SD 41 11.9
Years in practice, mean ! SD 9.7 11
Asthma patient over year, median (IQR) 50 75
IQR, Interquartile range.
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